A three-dimensional microfluidic tumor cell migration assay to screen the effect of anti-migratory drugs and interstitial flow

Johann Kalchman, Shingo Fujioka, Seok Chung, Yamato Kikkawa, Toshihiro Mitaka, Roger D. Kamm, Kazuo Tanishita, Ryo Sudo

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Most anti-cancer drug screening assays are currently performed in two dimensions, on flat, rigid surfaces. However, there are increasing indications that three-dimensional (3D) platforms provide a more realistic setting to investigate accurate morphology, growth, and sensitivity of tumor cells to chemical factors. Moreover, interstitial flow plays a pivotal role in tumor growth. Here, we present a microfluidic 3D platform to investigate behaviors of tumor cells in flow conditions with anti-migratory compounds. Our results show that interstitial flow and its direction have significant impact on migration and growth of hepatocellular carcinoma cell lines such as HepG2 and HLE. In particular, HepG2/HLE cells tend to migrate against interstitial flow, and their growth increases in interstitial flow conditions regardless of the flow direction. Furthermore, this migratory activity of HepG2 cells is enhanced when they are co-cultured with human umbilical vein endothelial cells. We also found that migration activity of HepG2 cells attenuates under hypoxic conditions. In addition, the effect of Artemisinin, an anti-migratory compound, on HepG2 cells was quantitatively analyzed. The microfluidic 3D platform described here is useful to investigate more accurately the effect of anti-migratory drugs on tumor cells and the critical influence of interstitial flow than 2D culture models.

Original languageEnglish
Pages (from-to)969-981
Number of pages13
JournalMicrofluidics and Nanofluidics
Volume14
Issue number6
DOIs
Publication statusPublished - 2013 Jun 1

Fingerprint

Microfluidics
Tumors
Assays
interstitials
drugs
tumors
Cells
Pharmaceutical Preparations
platforms
cells
Endothelial cells
cancer
Screening
veins
cultured cells
indication
screening
sensitivity
Direction compound

Keywords

  • 3D cell migration
  • Anti-migratory drugs
  • Interstitial flow
  • Microfluidics

ASJC Scopus subject areas

  • Condensed Matter Physics
  • Electronic, Optical and Magnetic Materials
  • Materials Chemistry

Cite this

A three-dimensional microfluidic tumor cell migration assay to screen the effect of anti-migratory drugs and interstitial flow. / Kalchman, Johann; Fujioka, Shingo; Chung, Seok; Kikkawa, Yamato; Mitaka, Toshihiro; Kamm, Roger D.; Tanishita, Kazuo; Sudo, Ryo.

In: Microfluidics and Nanofluidics, Vol. 14, No. 6, 01.06.2013, p. 969-981.

Research output: Contribution to journalArticle

Kalchman, Johann ; Fujioka, Shingo ; Chung, Seok ; Kikkawa, Yamato ; Mitaka, Toshihiro ; Kamm, Roger D. ; Tanishita, Kazuo ; Sudo, Ryo. / A three-dimensional microfluidic tumor cell migration assay to screen the effect of anti-migratory drugs and interstitial flow. In: Microfluidics and Nanofluidics. 2013 ; Vol. 14, No. 6. pp. 969-981.
@article{7b82e9dab48446649a272da4d9a771e4,
title = "A three-dimensional microfluidic tumor cell migration assay to screen the effect of anti-migratory drugs and interstitial flow",
abstract = "Most anti-cancer drug screening assays are currently performed in two dimensions, on flat, rigid surfaces. However, there are increasing indications that three-dimensional (3D) platforms provide a more realistic setting to investigate accurate morphology, growth, and sensitivity of tumor cells to chemical factors. Moreover, interstitial flow plays a pivotal role in tumor growth. Here, we present a microfluidic 3D platform to investigate behaviors of tumor cells in flow conditions with anti-migratory compounds. Our results show that interstitial flow and its direction have significant impact on migration and growth of hepatocellular carcinoma cell lines such as HepG2 and HLE. In particular, HepG2/HLE cells tend to migrate against interstitial flow, and their growth increases in interstitial flow conditions regardless of the flow direction. Furthermore, this migratory activity of HepG2 cells is enhanced when they are co-cultured with human umbilical vein endothelial cells. We also found that migration activity of HepG2 cells attenuates under hypoxic conditions. In addition, the effect of Artemisinin, an anti-migratory compound, on HepG2 cells was quantitatively analyzed. The microfluidic 3D platform described here is useful to investigate more accurately the effect of anti-migratory drugs on tumor cells and the critical influence of interstitial flow than 2D culture models.",
keywords = "3D cell migration, Anti-migratory drugs, Interstitial flow, Microfluidics",
author = "Johann Kalchman and Shingo Fujioka and Seok Chung and Yamato Kikkawa and Toshihiro Mitaka and Kamm, {Roger D.} and Kazuo Tanishita and Ryo Sudo",
year = "2013",
month = "6",
day = "1",
doi = "10.1007/s10404-012-1104-6",
language = "English",
volume = "14",
pages = "969--981",
journal = "Microfluidics and Nanofluidics",
issn = "1613-4982",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - A three-dimensional microfluidic tumor cell migration assay to screen the effect of anti-migratory drugs and interstitial flow

AU - Kalchman, Johann

AU - Fujioka, Shingo

AU - Chung, Seok

AU - Kikkawa, Yamato

AU - Mitaka, Toshihiro

AU - Kamm, Roger D.

AU - Tanishita, Kazuo

AU - Sudo, Ryo

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Most anti-cancer drug screening assays are currently performed in two dimensions, on flat, rigid surfaces. However, there are increasing indications that three-dimensional (3D) platforms provide a more realistic setting to investigate accurate morphology, growth, and sensitivity of tumor cells to chemical factors. Moreover, interstitial flow plays a pivotal role in tumor growth. Here, we present a microfluidic 3D platform to investigate behaviors of tumor cells in flow conditions with anti-migratory compounds. Our results show that interstitial flow and its direction have significant impact on migration and growth of hepatocellular carcinoma cell lines such as HepG2 and HLE. In particular, HepG2/HLE cells tend to migrate against interstitial flow, and their growth increases in interstitial flow conditions regardless of the flow direction. Furthermore, this migratory activity of HepG2 cells is enhanced when they are co-cultured with human umbilical vein endothelial cells. We also found that migration activity of HepG2 cells attenuates under hypoxic conditions. In addition, the effect of Artemisinin, an anti-migratory compound, on HepG2 cells was quantitatively analyzed. The microfluidic 3D platform described here is useful to investigate more accurately the effect of anti-migratory drugs on tumor cells and the critical influence of interstitial flow than 2D culture models.

AB - Most anti-cancer drug screening assays are currently performed in two dimensions, on flat, rigid surfaces. However, there are increasing indications that three-dimensional (3D) platforms provide a more realistic setting to investigate accurate morphology, growth, and sensitivity of tumor cells to chemical factors. Moreover, interstitial flow plays a pivotal role in tumor growth. Here, we present a microfluidic 3D platform to investigate behaviors of tumor cells in flow conditions with anti-migratory compounds. Our results show that interstitial flow and its direction have significant impact on migration and growth of hepatocellular carcinoma cell lines such as HepG2 and HLE. In particular, HepG2/HLE cells tend to migrate against interstitial flow, and their growth increases in interstitial flow conditions regardless of the flow direction. Furthermore, this migratory activity of HepG2 cells is enhanced when they are co-cultured with human umbilical vein endothelial cells. We also found that migration activity of HepG2 cells attenuates under hypoxic conditions. In addition, the effect of Artemisinin, an anti-migratory compound, on HepG2 cells was quantitatively analyzed. The microfluidic 3D platform described here is useful to investigate more accurately the effect of anti-migratory drugs on tumor cells and the critical influence of interstitial flow than 2D culture models.

KW - 3D cell migration

KW - Anti-migratory drugs

KW - Interstitial flow

KW - Microfluidics

UR - http://www.scopus.com/inward/record.url?scp=84879694397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879694397&partnerID=8YFLogxK

U2 - 10.1007/s10404-012-1104-6

DO - 10.1007/s10404-012-1104-6

M3 - Article

VL - 14

SP - 969

EP - 981

JO - Microfluidics and Nanofluidics

JF - Microfluidics and Nanofluidics

SN - 1613-4982

IS - 6

ER -